Strategic Value for Shareholders

Novartis strategy & value to shareholders were summarized for investors at 2024 J.P. Morgan Healthcare Conference.
With Novartis vision to become the most valued and trusted medicines company in the world, our CEO, Vas Narasimhan, highlighted how our focused strategy, continued investment, and commitment to shareholders support us in achieving this vision during the recent J.P. Morgan Healthcare Conference.
*This video uses audio from the webcasted event.*
J.P. Morgan Healthcare Conference
Event Date: January 08, 2024
Full webcast here: go.novartis.social/49012mq
Full presentation here: go.novartis.social/3UkSFOy
Novartis JPM HC 2024 Coverage: go.novartis.social/47XUyUl
Investor Relations: go.novartis.social/3OnNVDE
Investor Events: go.novartis.social/483r8Ew
Novartis Strategy: go.novartis.social/3Ul99Gf
Disclaimer: J.P. Morgan Healthcare Conference live event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: go.novartis.social/3UkSFOy
The J.P. Morgan Healthcare conference live event also contains non-IFRS measures. An explanation of non-IFRS measures can be found on our website go.novartis.social/49aL2OG.
Learn more: go.novartis.social/47XUyUl